Markets:

Overview

News

Currencies

International

Treasuries

Molecular Partners AG - American Depositary Shares (NQ:MOLN)

3.990 -0.130 (-3.16%)

Streaming Delayed Price Updated: 10:29 AM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Molecular Partners AG - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022 ↗

August 29, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 29, 2022

Via Benzinga

SVB Leerink Slashes Price Target On This Stock By Over 73%, Plus This Analyst Predicts $56 For Toll Brothers ↗

August 29, 2022

Citigroup raised the price target for MacroGenics, Inc. (NASDAQ: MGNX) from $13 to $16. MacroGenics shares rose 4.8% to $3.90 in pre-market trading.

Via Benzinga

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN

August 27, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Initial Public Offering Lawsuit

Earnings Scheduled For August 25, 2022 ↗

August 25, 2022

Companies Reporting Before The Bell • Gold Fields (NYSE:GFI) is likely to report earnings for its first quarter. • 111 (NASDAQ:YI) is projected to report earnings for its second quarter.

Via Benzinga

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN

August 24, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Initial Public Offering Lawsuit

NASDAQ: MOLN Shareholder Notice: Lawsuit Alleges Misleading Statements by Molecular Partners AG ↗

August 16, 2022

San Diego, CA -- (SBWIRE) -- 08/16/2022 -- An investor, who purchased shares of Molecular Partners AG (NASDAQ: MOLN), filed a lawsuit over alleged violations of Federal Securities Laws by Molecular...

Via SBWire

ROSEN, A LEADING AND RANKED FIRM, Encourages Molecular Partners AG Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - MOLN

August 12, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Initial Public Offering Lawsuit

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN

August 07, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Initial Public Offering Lawsuit

Molecular Partners AG Investigation: Robbins LLP is Investigating Molecular Partners AG (MOLN) on Behalf of Shareholders

July 28, 2022

From Robbins LLP

Via Business Wire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN

July 24, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Initial Public Offering Lawsuit

Bronstein, Gewirtz & Grossman, LLC Notifies Molecular Partners AG (MOLN) Investors of Class Action and Encourages Investors to Contact the Firm

July 19, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

INVESTOR NOTICE: Molecular Partners AG Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MOLN

July 18, 2022

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

MOLN INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN

July 16, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Initial Public Offering Lawsuit

Shareholder Update: Robbins LLP Reminds Investors of Class Action Against Molecular Partners AG (MOLN)

July 15, 2022

From Robbins LLP

Via Business Wire

MOLECULAR PARTNERS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Molecular Partners AG and Encourages Investors to Contact the Firm

July 14, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Molecular Partners AG (MOLN)

July 14, 2022

From Robbins LLP

Via Business Wire

INVESTOR ALERT: Molecular Partners AG Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MOLN

July 13, 2022

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

EQUITY ALERT: Rosen Law Firm Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action – MOLN

July 13, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Molecular Partners AG with Losses of $100,000 to Contact the Firm

July 13, 2022

From The Schall Law Firm

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Molecular Partners AG with Losses of $100,000 to Contact the Firm

July 12, 2022

From The Schall Law Firm

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022 ↗

May 25, 2022

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

May 18, 2022

We're getting ready for another full day of trading with a breakdown of the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

110 Biggest Movers From Friday ↗

May 16, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.

Via Benzinga

56 Stocks Moving In Friday's Mid-Day Session ↗

May 13, 2022

Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 13, 2022

Via Benzinga

23 Stocks Moving in Friday's Pre-Market Session ↗

May 13, 2022

Gainers OTR Acquisition Corp. (NASDAQ: OTRA) rose 88.7% to $18.21 in pre-market trading after filing on Thursday showed shareholders approved merger with Comera Life Sciences.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 13, 2022

Good morning! We're starting off the final day of the workweek with an overview of the biggest pre-market stock movers for Friday!

Via InvestorPlace

Why Molecular Partners Shares Are Falling ↗

April 28, 2022

Molecular Partners AG (NASDAQ: MOLN) shares are trading lower again Thursday on continued weakness after the company recently said its partner Novartis expects the FDA may require additional clinical...

Via Benzinga

61 Biggest Movers From Yesterday ↗

April 28, 2022

Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed a 10-year contract with Hot Oil Transport with...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.